TY - JOUR
T1 - MPL Baltimore mutation and thrombocytosis
T2 - Case report and literature review
AU - Shkalim-Zemer, Vered
AU - Dgany, Orly
AU - Krasnov, Tanya
AU - Yacobovich, Joanne
AU - Tamary, Hannah
PY - 2013/4
Y1 - 2013/4
N2 - Thrombocytosis is a common finding and is a frequent cause of referral for further investigation. The MPL Baltimore (Lys39Asn) mutation has been reported as a cause of thrombocytosis in 7% of African Americans. We describe an 11-month-old Ethiopian Jewish boy referred for evaluation of thrombocytosis who was found to be homozygous for MPL Baltimore. So far, there is no indication whether patients with thrombocytosis who have this mutation, particularly homozygotes, are at increased risk of thrombotic or hemorrhagic complications. Nevertheless, this entity should be considered in the differential diagnosis of every patient with thrombocytosis, particularly those of African origin.
AB - Thrombocytosis is a common finding and is a frequent cause of referral for further investigation. The MPL Baltimore (Lys39Asn) mutation has been reported as a cause of thrombocytosis in 7% of African Americans. We describe an 11-month-old Ethiopian Jewish boy referred for evaluation of thrombocytosis who was found to be homozygous for MPL Baltimore. So far, there is no indication whether patients with thrombocytosis who have this mutation, particularly homozygotes, are at increased risk of thrombotic or hemorrhagic complications. Nevertheless, this entity should be considered in the differential diagnosis of every patient with thrombocytosis, particularly those of African origin.
KW - Children
KW - MPL Baltimore
KW - Thrombocytosis
UR - http://www.scopus.com/inward/record.url?scp=84876120392&partnerID=8YFLogxK
U2 - 10.1097/MPH.0b013e318286d54c
DO - 10.1097/MPH.0b013e318286d54c
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.systematicreview???
C2 - 23511495
AN - SCOPUS:84876120392
SN - 1077-4114
VL - 35
SP - e112-e114
JO - Journal of Pediatric Hematology/Oncology
JF - Journal of Pediatric Hematology/Oncology
IS - 3
ER -